On Tuesday, Verona Pharma Plc ADR (NASDAQ: VRNA) opened lower -0.54% from the last session, before settling in for the closing price of $27.62. Price fluctuations for VRNA have ranged from $11.39 to $28.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -39.77% over the last five years. Company’s average yearly earnings per share was noted -188.89% at the time writing. With a float of $62.75 million, this company’s outstanding shares have now reached $80.44 million.
The firm has a total of 79 workers. Let’s measure their productivity. In terms of profitability, gross margin is 4.57%, operating margin of -13794.21%, and the pretax margin is -13440.9%.
Verona Pharma Plc ADR (VRNA) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Verona Pharma Plc ADR is 22.61%, while institutional ownership is 62.21%. The most recent insider transaction that took place on Aug 13 ’24, was worth 1,275,681. In this transaction President and CEO of this company sold 398,400 shares at a rate of $3.20, taking the stock ownership to the 15,850,704 shares. Before that another transaction happened on Aug 12 ’24, when Company’s President and CEO sold 1,600 for $3.13, making the entire transaction worth $5,008. This insider now owns 16,249,104 shares in total.
Verona Pharma Plc ADR (VRNA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -188.89% per share during the next fiscal year.
Verona Pharma Plc ADR (NASDAQ: VRNA) Trading Performance Indicators
Check out the current performance indicators for Verona Pharma Plc ADR (VRNA). In the past quarter, the stock posted a quick ratio of 8.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.56, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.20 in one year’s time.
Technical Analysis of Verona Pharma Plc ADR (VRNA)
Analysing the last 5-days average volume posted by the [Verona Pharma Plc ADR, VRNA], we can find that recorded value of 1.4 million was better than the volume posted last year of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 85.95%. Additionally, its Average True Range was 1.65.
During the past 100 days, Verona Pharma Plc ADR’s (VRNA) raw stochastic average was set at 92.20%, which indicates a significant increase from 86.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.98% in the past 14 days, which was higher than the 64.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.86, while its 200-day Moving Average is $16.85. Now, the first resistance to watch is $28.20. This is followed by the second major resistance level at $28.93. The third major resistance level sits at $29.52. If the price goes on to break the first support level at $26.88, it is likely to go to the next support level at $26.29. Should the price break the second support level, the third support level stands at $25.56.
Verona Pharma Plc ADR (NASDAQ: VRNA) Key Stats
There are currently 79,940K shares outstanding in the company with a market cap of 2.23 billion. Presently, the company’s annual sales total 0 K according to its annual income of -54,370 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -70,840 K.
